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Abstract  
Placebo analgesia, reductions in pain following administration of an inert treatment, is a well-
documented phenomenon. We report the first demonstration that placebo analgesia can be 
experienced when a sham analgesic is applied onto a rubber hand. The effect was obtained by exploiting 
the rubber hand illusion, in which ownership is felt over a rubber arm that is unattached to the body. 
Under conditions of both synchronous and asynchronous visuo-tactile stimulation, a thermal pain 
stimulus was delivered on the real arm of twenty participants and seemingly also on the rubber arm, 
before and after applying a sham analgesic and a control cream only to the rubber arm. During 
synchronous visuo-tactile stimulation, pain was experienced on the rubber arm, and the application of 
the sham analgesic to the rubber arm significantly decreased the severity of reported pain. This 
demonstrates that experience of the body can modulate expectations and the induction of placebo 
analgesia.   
 
Perspective 
This article presents an experiment suggesting that a placebo treatment applied to a rubber hand during 
the rubber hand illusion can produce placebo analgesia. This finding indicates that embodiment may 
influence the placebo effect, a previously unexamined factor in the treatment process with potential 
applications to treatment administration. 
 
Keywords: Placebo Effect, Placebo Analgesia, Rubber Hand Illusion, Body Ownership, Embodiment 
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Introduction 
The mechanisms through which our beliefs alter our perception and physiological processes remains an 
intriguing area of psychological research, with the placebo effect being a prime example of this 
phenomenon. The placebo effect is the portion of therapeutic improvement attributable to 
psychobiological components following the receipt of an inert treatment, distinct from factors such as 
spontaneous remission and response bias.
6
 One of the best understood placebo effects is placebo 
analgesia, which is a robust phenomenon during both active pharmacological
7 42
 and inert treatments.
44
 
Placebo analgesia is mediated by conscious expectations, influenced by forms of learning such as verbal 
cues, classical conditioning, and social observation.
14 15 48
 A recent meta-analysis
2
 indicates that these 
conscious expectations mediate placebo analgesia through prefrontal regions,
41 52
 leading to activation 
of the descending pain modulatory system.
7 18 
 This network then employs the endogenous opioid 
system and μ-opioid neurotransmission
5
 decreasing activity in pain-processing regions
52
 as well as 
modulating nociceptive processing at the spinal level,
19 40
 inducing analgesia. 
To date, extensive research has examined how expectations influence both the occurrence and 
degree of placebo analgesia.
48 
Such studies have focused on manipulating the treatment itself, either 
through its characteristics,
9 16
 or through pharmacological
16
 or non-pharmacological conditioning 
procedures.
44
 No research, however, has examined how experience of the body, as opposed to 
perception of the treatment itself or its efficacy, influences expectations and placebo analgesia. A 
potential avenue for such investigations is the experimental manipulation of experience of ownership 
felt over the body, obtained by controlling the information inputted into multisensory processing 
systems. An ideal example of this is the rubber hand illusion (RHI), in which an artificial arm not 
connected to the body is subjectively experienced as part of the body through the integration of 
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temporally and spatially congruent tactile and visual information.
49
 The RHI is one of the few reliable 
scientific paradigms to investigate body ownership, and has been extensively studied both behaviourally 
and neurologically.
50
 Those subject to this phenomenon report touch and pain
11
 occurring on the rubber 
hand alongside a sense of ownership.
8 49 50
 Further, threatening the rubber hand during the illusion 
modulates anxiety-related activity in the anterior cingulate cortex,
17
 suggesting that interactions with 
the artificial limb may influence affective responses, altering pain-related neural activity. Indeed, recent 
research also indicates that the application of acupuncture to the limb during experience of the illusion 
produces subjective sensations associated with this treatment which were correlated with neural 
activity in the interoceptive system.
12 13
 
Given that the limb is experienced as part of the body, that patterns of neural activity appear to 
reflect some integration with the pain matrix, and that other somatosensory networks respond to 
interactions with the limb, it appears possible that a treatment applied to the artificial limb itself could 
modulate expectations, and thus, the experience of pain. The present study aimed to test this 
hypothesis using a procedure in which the RHI was induced during a conditioned placebo paradigm, 
wherein the placebo and control treatments were applied to the artificial limb itself. This procedure was 
completed under conditions of both synchronous and asynchronous visuo-tactile stimulation.  
Methods 
Participants 
Power analysis, using an alpha level of 5% and power of 95%, was conducted on the pooled effect size of 
studies investigating placebo analgesia between 2002 and 2007 (d = 0.81
51
). This estimated that a 
sample size of 20 would demonstrate a similar effect of a placebo treatment. Based on the literature 
regarding the RHI,
8
 this sample size was also sufficient to observe an effect of the illusion. Twenty right-
handed undergraduate students (13 female) from the University of Hull (mean age 21.25, SD = 6.06, 
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range = 18-43) participated in the experiment for course credit. Participants were reimbursed £16 for 
their participation. Exclusion criteria for the experiment, listed on the advertisement and confirmed 
upon arrival, were the current use of any prescribed or unprescribed analgesics, any previous or existing 
pain condition, as well as the right-hand being the non-dominant hand. Ethical approval was provided by 
the University of Hull departmental ethical committee and conformed to British Psychological Society 
guidelines. 
Design 
The experiment used a 2 (synchronous tactile stimulation, asynchronous tactile stimulation) x 2 (placebo 
treatment, control treatment) x 3 (pre-treatment, conditioning, post-treatment) repeated measures 
design. Participants experienced two sessions of placebo and control treatments differing in the 
synchronicity of tactile stimulation, each involving three phases of nociceptive stimulation.  
Rubber Hand Illusion 
A partition placed on a table to the right of the participants’ midline blocked the view of the real arm, 15 
cm away on the left of the partition was placed an artificial limb. Two rubber hands were used, one 
female (42 cm in length) and one male (49 cm in length) (right-handed PVC prosthetic arm covers filled 
with foam beads [RSL Steeper, Leeds, United Kingdom]). 
In the synchronous condition the participant’s and rubber hand's middle fingers were stimulated 
in a synchronous fashion using a repeating cycle of a stroke (distally from the dorsal proximal 
interphalangeal to the eponychium), a tap (directed toward the dorsal proximal interphalangeal),  and a 
lift (raising the finger by 30°  before letting it drop back to the table). Each cycle was completed at a rate 
of 0.3 Hz. In the asynchronous condition this stimulation was performed in an asynchronous fashion. 
Based on the results of a pilot study, an adapted version of the Botvinick and Cohen 
questionnaire,
8
 tailored to specifically address subjective sense of ownership and displacement of tactile 
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and nociceptive sensation onto the artificial limb, was used to measure the RHI (Table 1). Participants 
were prompted to first respond ‘yes’ or ‘no’ to each question. Only after ‘yes’ responses they were 
asked to rate how strong the sensation was on a 1-5 numerical rating scale, with ‘1’ being labelled ‘very 
mild’ and ‘5’ being labelled ‘very strong’. A ‘no’ response was scored as a ‘0’ on the rating scale. This 
choice was added in order to ensure that an absence of the illusion was consistently rated by 
participants in line with some established measures of anomalous experiences.
4
 
Proprioceptive drift was recorded using a task in which participants closed their eyes and 
estimated the location of their right arm beneath the table using their left hand both before and after 
the induction of the illusion. Under the table a 100 cm tape measure was attached, using which the 
experimenter recorded where the participant estimated their arm to be. For each participant, the 
baseline estimate was subtracted from the estimate made after visuo-tactile stimulation in each phase 
in order to measure the perceived drift in felt arm position brought about by the RHI. 
Thermal Stimuli 
A contact thermode (Pathway CHEPS, Medoc, Ramat Yishai, Israel) was used to accurately deliver 
thermal nociceptive stimuli. A second mock thermode was attached to the rubber hand, and had a built-
in visual stimulus (a red LED light) which could be manually activated by the experimenter. All stimuli in 
the experiment used the ‘Ramp and Hold’ setting, increasing in temperature at a rate of 10°C per second 
from a baseline of 35°C, before maintaining at the destination temperature for the remainder of the 5 
second duration. 
Participants’ perception of pain was measured using two rating scales, one assessing pain 
intensity (sensory dimension of pain – 0 corresponded to ‘No Pain’; ‘100’ to ‘Intolerable Pain’) and the 
other pain unpleasantness (affective dimension of pain – 0 was ‘Not Unpleasant At All’ and 100 ‘Most 
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Unpleasant Imaginable’).  Scales were printed and placed on the table in front of the participant and 
remained visible throughout the experiment. 
Each session started with a calibration procedure
44
 in order to tailor the strength of the pain 
stimuli to each individual.  Four thermal stimuli (44°C, 45°C, 47°C, & 49°C) were each applied twice in a 
randomised order to the selected location, which depended on the counterbalancing order for that 
individual. Participants rated the pain intensity of each thermal stimulus using the aforementioned 
scale.  Using these ratings, the temperature deemed to represent the high (60 on the numerical scale) or 
low (30 on the numerical scale) intensity stimulus for each participant was calculated using a regression 
analysis.  
Placebo Treatment 
Small white containers stored the inert placebo treatment and control cream. The placebo treatment 
was a mixture of E45 moisturising cream and alcohol sanitiser (to give the placebo treatment a chemical 
odour), while the control cream did not contain the alcohol sanitiser. The containers’ labelling (“Hull 
York Medical School – Topical Anaesthetic Lidocaine – Authorized for Research Purposes Only” on the 
placebo treatment and “Aqueous Cream” on the control treatment) was consistent with previous 
research on the placebo effect.
30 44
 The placebo treatment was applied using surgical gloves. In order to 
improve the psychosocial context, the experimenter also wore a white lab coat throughout the 
procedure, and the study was conducted in a room labelled “Behavioural Medicine Laboratory”. This 
pretext, environment, and means of treatment administration reliably induced a placebo effect with 
conditioning in pilot testing. 
Procedure 
The experiment was advertised as a study examining the effect of analgesics during the RHI. Participants 
were told that they were to rate their experience of pain in a number of pain trials during two different 
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conditions of the RHI, and to complete a number of questionnaires regarding their experience of the 
illusion. They were also informed that after a number of trials the analgesic treatment and the control 
treatment would be applied to the artificial limb itself. To clarify this, participants were informed of the 
preliminary nature of the study, told that it was not clear what effect this analgesic could have during 
this procedure, and that while this was an unusual method they should continue to accurately report 
their genuine pain experience throughout the experiment. Participants then provided informed consent 
to take part in the study. 
The experiment was conducted in two sessions, separated by approximately two weeks in order 
to reduce any effects of habituation to pain. In each session, participants were seated at a table, with 
both hands flat on the table in front of them. On the table was the experimental set-up for the RHI 
described above. At the beginning of the experiment, two sites of the real right arm (and corresponding 
sites on the rubber hand) were identified. These sites were medially located on the dorsal surface of the 
right forearm, with site A being distally located and site B in a proximal position (see Figure 1). These 
two locations would be used as stimulation sites where the placebo and control treatments would later 
be applied, with thermal stimulation alternating between the two sites. Both the thermode on the real 
arm and the mock thermode on the artificial limb were moved in unison so that they were always 
located on the corresponding site between the two limbs. The two sessions varied in regard to the 
synchronicity of visuo-tactile stimulation, while factors such as the initial site of thermal stimulation and 
the location of the placebo treatment on the rubber arm were maintained between the two sessions 
(i.e. a participant for whom site A was both the first site of stimulation and the location of the placebo 
treatment during synchronous stimulation would also undergo the same during asynchronous 
stimulation). The order of sessions (synchronous, asynchronous), the initial site of stimulation, and the 
location of the placebo treatment were all counterbalanced between participants. 
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Each session consisted of 14 blocks of thermal stimulation, split into three phases, pre-
conditioning (baseline), conditioning, and post-conditioning. Each block of stimuli contained four 
individual thermal stimuli (see Table 2), and alternated between the two sites on the participant’s right 
forearm. A baseline of ‘60’ perceived pain intensity was used. 
 Visuo-tactile stimulation was applied for 45 seconds before starting the thermal stimulation, 
and was maintained throughout each block. Measures of the RHI (questionnaires and proprioceptive 
drift) were taken throughout the experiment following the 3
rd
, 4
th
, 7
th
, 8
th
, 13
th
 and 14
th
 blocks. During 
each thermal stimulus, the red LED on the mock thermode placed on the rubber arm was manually 
operated by the experimenter, with the light signalling the onset and duration of each stimulus. During 
each of these blocks participants were instructed to focus their attention on the artificial limb, 
specifically where the tactile stimulation was occurring.   
Pre-Conditioning Phase 
During the pre-conditioning phase, the thermode and mock thermode were attached to the 
participant’s arm and the artificial limb. Site was similarly counterbalanced on both real and rubber arm. 
After applying visuo-tactile stimulation, a first block of high intensity (‘60’ perceived intensity) thermal 
stimuli was administered. The same procedure was repeated until two blocks of stimulation had been 
applied on each site. Participants verbally rated the perceived pain intensity and unpleasantness of each 
individual stimulus. After the 3
rd
 and 4
th
 blocks of stimulation, participants completed the RHI 
questionnaire and performed the measure of proprioceptive drift.  
Conditioning Phase  
Following completion of the pre-conditioning phase two creams were presented.  Participants were told 
that one was a powerful analgesic called lidocaine, whereas the other was a simple moisturising cream. 
The sham analgesic was applied with latex gloves to the treatment site of the rubber limb. Location of 
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sham analgesic and control creams on the artificial limb was counterbalanced between participants. 
After applying the placebo or the moisturiser, the thermode and the mock thermode were then 
reattached on the participant’s arm and the rubber limb, with half of the participants starting with the 
treatment site and half with the control site. The RHI was then induced and the blocks of thermal 
stimulation repeated as during the pre-treatment phase, with the exception that stimulation at the 
sham analgesic site was surreptitiously applied at a low ‘30’ perceived pain intensity. This was to induce 
a strong expectancy that the sham analgesic treatment would decrease perceived pain.
34
 This method 
was repeated for a total of six blocks of stimulation. Measures of the RHI were obtained following the 7
th
 
and 8
th
 blocks of stimulation. Two further blocks of conditioning stimulation were then conducted after 
this in order to ensure the transition from the conditioning to post-conditioning phase was as seamless 
as possible. This was done in order to reduce detection of change in the experimental method. 
Post-Conditioning Phase  
This phase immediately followed the conditioning phase, with the procedure and duration being 
identical to the pre-treatment phase. The blocks of thermal stimulation at the site that previously 
received the low intensity stimulation in the conditioning phase were surreptitiously increased to the 
same high intensity stimulation level as that of the control site (i.e. ‘60’ perceived pain intensity). A total 
of four blocks of thermal stimulation were applied in an alternating pattern between stimulation sites 
(see Figure 2). Measures of the RHI were collected following the completion of the post-treatment 
phase after the 13
th
 and 14
th
 blocks of stimuli. 
Statistical Analyses 
Data were collapsed across stimulation site A and B for the purposes of data analysis. Baseline 
comparisons of pain intensity and unpleasantness across conditions of synchronicity and treatment 
were conducted using one-way repeated measures ANOVAs. Data from all outcomes were analysed 
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using 2 (synchronous, asynchronous) x 2 (placebo, control) x 2 (pre-treatment, post-treatment) repeated 
measures ANOVAs. Post-hoc analysis of these outcomes were performed using both simple effects 
analysis and post-hoc t-tests adjusted for multiple comparisons using the Bonferroni correction. Finally, 
correlational analyses were performed using Pearson bivariate correlations (two-tailed). 
Results 
Baseline Assessment 
Baseline comparisons revealed no significant differences in pain intensity: F(3, 57) = 1.146, p = .339, or 
unpleasantness: F(3, 57) = 1.324, p = .275, between treatment sites or conditions of synchronicity. 
Rubber Hand Illusion 
All three subscales of the questionnaire (ownership, tactile embodiment, and nociceptive 
embodiment) were higher during synchronous as compared to asynchronous stimulation (Table 3). The 
range of data was ‘5’ across all three subscales during synchronous stimulation and varied between ‘4’ 
and ‘5’ during asynchronous stimulation. A reliability analysis performed on the RHI questionnaire 
revealed Cronbach's alphas from .94 to .96 (mean = .95) during synchronous stimulation, and from .89 
to .95 (mean = .93) during asynchronous stimulation. A bivariate correlation analysis revealed that the 
three subscales were significantly correlated with each other (p < .01 or p < .05) across all phases, at 
both treatment sites, and under both conditions of stimulation synchronicity (from r = .67 to r = .95 
[mean r = .81] during synchronous, and from r = .56 to r = .96 [mean r = .78] during asynchronous 
stimulation). Experience of the RHI was considered as a rating of greater than ‘1’ and was assessed by 
collapsing each subscale across both treatment sites and all three phases of the experiment. During 
synchronous visuo-tactile stimulation 75% of participants reported experiencing ownership over the 
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rubber hand and a sense of tactile embodiment, whereas 55% reported the embodiment of pain onto 
the artificial limb (see Supplementary Materials for analyses with non-responders excluded). 
Four three-way 2x2x2 repeated measures ANOVAs were conducted on the measures of the RHI, 
using synchronicity (synchronous, asynchronous), treatment (placebo, control), and phase (pre-
treatment, post-treatment) as within-subjects factors. The first of these examined average responses to 
question one, which assessed experience of ownership over the rubber hand, finding a significant main 
effect of synchronicity: F(1, 19) = 10.074, p = .005, ηp
2
 = .346, d = 0.55, 95% CI for synchronous [1.59, 
3.26] and asynchronous conditions [0.80, 2.22], indicating that synchronous visuo-tactile stimulation 
lead a greater sense of ownership over the rubber hand compared to asynchronous visuo-tactile 
stimulation. A significant interaction was also observed between synchronicity and treatment: F(1, 19) = 
5.942, p = .025, ηp
2
 = .238, in which there appears to be a greater disparity in ownership between the 
synchronous and asynchronous conditions at the control site in comparison to the placebo site. All other 
effects and interactions failed to reach significance (largest F(1, 19) = 1.355, p = .259). 
Four post-hoc t-tests were performed to examine the interaction between synchronicity and 
treatment on subjective sense of ownership over the rubber hand (after a Bonferroni correction, alpha 
value of 0.0125). These analyses found that ownership was significantly greater during synchronous 
stimulation at both the placebo site: t(19) = 2.97, p = .008 and the control site : t(19) = 3.58, p = .002, 
compared to during asynchronous stimulation. As this difference was larger at the control site, however, 
it appears that a greater disparity in subjective ownership at the control site in comparison to the 
placebo site underlies this interaction. 
Analysis of the subscale of tactile embodiment, which comprised of the averaged response to 
questions four and five, found no significant main effects or interactions (largest F(1, 19) = 2.879, p = 
.106). The subscale of pain embodiment which comprised of the averaged response of questions two 
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and three was then analysed, finding a significant main effect of synchronicity: F(1, 19) = 8.836, p = .008, 
ηp
2
 = .317, d = 0.52, 95% CI for synchronous [0.95, 2.63] and asynchronous conditions [0.36, 1.59], 
suggesting that the embodiment of pain was greater during synchronous visuo-tactile stimulation 
compared to asynchronous stimulation. All other effects and interactions failed to reach significance 
(largest F(1, 19) = 2.999, p = .100). A final ANOVA examined the behavioural measure of proprioceptive 
drift, finding no significant main effects or interactions (largest F(1, 19) = 2.013, p = .172). 
Pain Intensity 
Visual inspection of the data suggests that pain intensity decreased at the placebo site and increased at 
the control site when comparing pre and post-conditioning treatment, but only during the synchronous 
stimulation. A notable disparity in baseline ratings between treatment sites during asynchronous 
stimulation was also observed (Table 4). 
The 2 (synchronous, asynchronous) x 2 (placebo, control) x 2 (pre-treatment, post-treatment 
phase) repeated measures ANOVA on average pain intensity ratings revealed a main effect of treatment: 
F(1, 19) = 5.87, p =  .026, ηp
2
 = .236, qualified, more importantly, by a significant interaction between 
treatment and phase: F(1, 19) = 5.28, p =  .033, ηp
2
 = .237, and a significant three-way interaction: F(1, 
19) = 14.02, p = .001, ηp
2
 = .425. All other main effects and interactions failed to reach significance (Fs < 
1). 
A simple effects analysis conducted in order to examine the three-way interaction revealed a 
significant effect of treatment during synchronous stimulation in the post-treatment phase: F(1, 76) = 
16.11, p < .000, indicating that the placebo treatment decreased pain intensity but only during 
synchronous stimulation. It also revealed a significant effect of phase at the placebo site during 
synchronous stimulation: F(1, 76) = 4.30, p = .042, indicating that pain ratings decreased only at the 
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placebo treatment site following receipt of the treatment, and only during synchronous stimulation. All 
other effects failed to reach significance (largest F(1, 76) = 3.29, p = .074). 
Based on the results of the simple effects analysis, two post-hoc t-tests performed on the three-
way interaction (after a Bonferroni correction, alpha value of 0.025), finding a significant difference in 
pain intensity ratings between the placebo and control sites in the post-treatment phase during 
synchronous stimulation: t(19) = 3.36,  p = .002, d = 0.75. The difference in pain intensity between the 
pre and post-treatment phases at the placebo site during synchronous stimulation failed to reach 
significance: t(19) = 1.96,  p = .066. These results indicate that the decrease in pain intensity occurred 
only in the post-treatment phase, was specific to the placebo treated location, and was significantly 
stronger during synchronous than asynchronous stimulation (Figure 3). 
Pain Unpleasantness 
Data on pain unpleasantness were similar to data on pain intensity in that during synchronous 
stimulation unpleasantness decreased at the placebo site and increased at the control site, whereas 
during asynchronous stimulation ratings either increased or were stable. Further, a substantial disparity 
in baseline ratings between the two sites was observed during asynchronous stimulation (Table 5). 
The 2x2x2 ANOVA on average pain unpleasantness ratings also found a significant main effect of 
treatment: F(1, 19) = 6.95, p = .016, ηp
2
 = .268, as well as an interaction between phase and treatment, 
F(1, 19) = 4.47, p = .048, ηp
2
 = .190. More importantly, the three-way interaction between treatment, 
synchronicity and phase was significant: F(1, 19) = 6.66, p = .018, ηp
2
 = .260. The other main effects and 
interactions failed to reach significance (Fs < 1). 
A simple effects analysis conducted in order to examine the three-way interaction revealed a 
significant effect of treatment during synchronous stimulation in the post-treatment phase: F(1, 76) = 
12.30, p = .001, a significant effect of treatment during asynchronous stimulation in the pre-treatment 
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phase: F(1, 76) = 4.11, p = .046, as well as a significant effect of phase at the control site during 
synchronous stimulation: F(1, 76) = 5.99, p = .017. All other effects failed to reach significance (largest 
F(1, 76) = 3.01, p = .087). 
Based on the results of the simple effects analysis, three post-hoc t-tests performed on the 
three-way interaction (after a Bonferroni correction, alpha value of 0.016), finding a significant 
difference in pain unpleasantness ratings between the placebo and control sites in the post-treatment 
phase during synchronous stimulation: t(19) = 3.16,  p = .005, d = 0.58. A significant increase in 
unpleasantness ratings was also found between the pre and post-treatment phases at the control site 
during synchronous stimulation: t(19) = 3.01, p = .007, d = 0.44. The difference between the two 
treatment sites in the pre-treatment phase during asynchronous stimulation failed to reach significance: 
t(19) = -2.19, p = .041. This suggests that the disparity in baseline scores did not contribute significantly 
to the three-way interaction. These findings indicate that only during synchronous stimulation did the 
application of the placebo treatment lead to changes in unpleasantness ratings between the two sites, 
which was accompanied by significant sensitisation through the course of the experiment at the control 
site (Figure 4).  
Correlational Analysis 
In order to examine the relationship between experience of the RHI and the induction of placebo 
analgesia through the rubber arm, a correlational analysis was performed on results from the placebo 
treatment site during synchronous visuo-tactile stimulation. Measures of pain intensity and 
unpleasantness, specifically ratings during the post-treatment phase and the difference between the pre 
and post-treatment phases, were correlated with the three subscales of the RHI during both the pre and 
post-treatment phases (Table 6). Besides expected correlations within measures of pain and the RHI, 
this analysis revealed significant negative correlations between the difference in pain intensity from the 
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pre to the post-treatment phase with pain embodiment during the post-treatment phase (r = -.483, p = 
.031), as well as the difference in pain unpleasantness between the pre and post-treatment phases with 
pain embodiment during the pre-treatment phase (r = -.467, p = .038). These correlations indicate that a 
larger reduction in pain intensity and unpleasantness following receipt of the treatment was associated 
with greater reporting of pain as occurring on the rubber hand during either the post or pre-treatment 
phases respectively. 
Discussion 
This is the first demonstration that placebo analgesia can be induced through the application of a 
treatment to an artificial limb that is ostensibly unattached to the body. Previous research on the RHI 
demonstrated that pain can be experienced as occurring on the rubber hand through synchronous 
nociceptive input,
11
 and that threatening the artificial limb produces patterns of neural activity similar to 
threatening the actual arm.
17
 Here we demonstrate that a reduction in pain attributable to the placebo 
effect is experienced when a placebo treatment is applied to the rubber arm. Crucially, and in line with 
research on the RHI,
8 50
 this placebo effect only occurs when the RHI is induced, that is, during 
synchronous stimulation. As this effect is specific to the placebo treatment site during synchronous 
stimulation, it is unlikely to be a product of the visual cue on the mock thermode, attention, or the RHI 
itself, as such explanations would also predict a reduction in pain at the control site. As such, this finding 
also replicates previous research indicating that the RHI has no analgesic effect.
31 
Further, conditioned 
pain modulation cannot account for the results, as such an explanation would also expect a reduction in 
pain during asynchronous stimulation.   
These findings are not only novel, but also build upon recent research on the RHI indicating that 
the experience of embodiment over the rubber hand may interact with the top-down modulation of 
sensory experience. In particular, research examining the application of acupuncture to the rubber hand 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
17 
 
found that it may produce subjective sensations associated with this form of treatment, as 
demonstrated by correlations between these measures and activity in a variety of regions associated 
with the RHI.
12 13
 These studies, however, only assessed subjective sensory phenomena associated with 
acupuncture, as opposed to its actual therapeutic efficacy. As such, the present study represents a 
significant advancement, as it suggests that multisensory processing, and the resulting sense of 
embodiment, may influence expectations regarding the efficacy of a treatment, in turn reducing 
symptoms through the placebo effect. In other words, when a topical treatment is applied to the 
artificial limb during experience of the illusion, there are increased expectations that it may influence 
pain perception, relative to when the illusion is absent. These expectations, bolstered by the 
conditioning procedure, then lead to placebo analgesia through the descending pain modulatory 
system.  
Besides a reduction in pain only being observed during synchronous visuo-tactile stimulation, 
further evidence for this account can be seen in the correlations between the experience of pain as 
occurring on the rubber hand and changes in pain intensity and unpleasantness following receipt of the 
treatment. This suggests that the displacement of pain was particularly relevant to expecting a 
treatment applied in this manner to alter pain experience. While it is somewhat surprising that this 
sensation, as opposed to the sense of ownership over the rubber hand, modulated placebo analgesia, it 
nonetheless provides additional evidence that the illusory experience of the RHI was integral to the 
observed effect. To date, little is known as to how perceptual displacement of pain in the RHI relates to 
both ownership and the displacement of touch. Models of the RHI indicate that the referral of touch to 
the rubber hand based on the concurrent visual and tactile information is a prerequisite for ownership,
50
 
though the related functionality of pain referral is unknown. One possibility is a parallel recalibration 
alongside touch, which raises the question of whether the displacement of pain may be induced in 
isolation from tactile input, as well as whether this is sufficient to induce ownership.  Examining such 
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questions may elucidate the displacement of pain and how it contributed to the induction of placebo 
analgesia in this study. 
One interesting notion regarding these findings is the extent to which embodiment is a 
necessary prerequisite for placebo analgesia.  While no research has directly addressed this possibility, 
there is a growing body of evidence indicating that chronic pain conditions are associated with distorted 
body representation.
37
 In particular, such distortions have been observed in complex regional pain 
syndrome (CRPS)
25 35 38
 and chronic back pain.
10 36
 If embodiment is necessary for placebo analgesia then 
it would be expected that such conditions would display impaired placebo effects when the treatment is 
applied to the afflicted region. Previous research, however, has observed considerable pain relief 
following receipt of a placebo treatment in both CRPS
43
 and chronic back pain.
22 
Nonetheless, it should 
be noted that these studies did not directly measure bodily distortions, nor did they compare the degree 
of pain relief with a relevant control sample, and so an association cannot be entirely ruled out. 
 The analgesic effect observed in this study also bears some similarities to visually induced 
analgesia, in which sight of the body itself can reduce pain perception.
27 31
 In this phenomena, 
information about the body, typically visual input regarding the body part in pain, has an inherent 
analgesic effect. This response is driven by bottom-up processing, wherein visual information about the 
body, processed in parietal and occipital regions related to the representation of body, instigates the 
descending modulation of pain without higher-order frontal regions.
28
 Similar effects have also been 
observed using the RHI in virtual environments,
32 39 
and may provide an explanation, through factors 
such as colocation with the body, as to inconsistencies in the literature regarding whether the RHI itself 
has an analgesic effect.
23 33
 In contrast, the specificity of analgesia to the treatment site during 
synchronous visuo-tactile stimulation in the present study suggests that top-down expectations of pain 
relief following receipt of a treatment were modulated by whether pain was referred to the location of 
the treatment.  The neural mechanisms underpinning this likely involve activation of the descending 
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pain modulatory system through lateral prefrontal regions,
2
 precluded by a recalibration of felt pain 
through multisensory processing regions in the premotor and parietal cortices.
50
 In this manner, the two 
phenomena represent contrasting methods by which information about the body may instigate the 
descending modulation of pain.  
As this is the first study to demonstrate an interaction between the placebo effect and 
embodiment, subsequent studies should also examine the boundaries of this effect, and map the extent 
to which similarity
20
 or distance
26 
between the rubber limb and the body, factors which modulate the 
RHI, may alter the degree of placebo analgesia. Future studies should also examine the role of visual 
information in shaping this effect, and whether placebo analgesia can be induced using the non-visual 
variant of the RHI.
29
 
The finding that embodiment of pain may influence treatment expectations paves the way for 
further, more elaborate investigations of how experience of the body may interact with the placebo 
effect. There is a growing field of research examining embodiment in immersive virtual reality.
24 47
 Such 
techniques allow for the precise control of the presented environments and pose an interesting avenue 
for investigating treatment expectations and embodiment. Intriguingly, recent research has found that 
virtual reality techniques, such as visual feedback regarding movement, may alter the experience of 
pain.
21
 The findings from the present study suggest that the application of a treatment within such a 
virtual environment, alongside the appropriate conditioning procedures, may have the potential to 
induce placebo analgesia.   
The results of this study are also consistent with previous research on the placebo effect, which 
indicate that the manipulation of information regarding the placebo treatment, such as its 
characteristics
9 16
 or the perceived likelihood of receiving an active treatment,
45
 alters understanding of 
the treatment and thus affects expectations. These expectations then modulate the placebo effect. The 
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present study, however, represents an intriguing demonstration of the influence of expectancy on the 
placebo effect, as it is the subjective experience of what is part of the body that is manipulated, rather 
than the characteristics of the treatment itself or the perceived likelihood of receipt. Our findings show 
that manipulations of bodily experience may result in placebo analgesia when the location of the 
treatment is moved outside of the body itself. This is a powerful demonstration of the influence of 
expectations on the induction of placebo analgesia, as well as a unique example of the factors that may 
influence expectations. 
Non-pharmacological conditioning procedures have also been consistently demonstrated to be 
a powerful means of manipulating learning in regard to placebo analgesia.
48
 It may be that the 
conditioning procedure is essential in the present paradigm to induce the expectancy that the treatment 
is effective. Future studies may wish to address this question by attempting to replicate the current 
findings using an experimental paradigm in which the conditioning procedure is removed.   
While the present study examined how treatments applied to the artificial limb may influence 
experimentally induced pain, an intriguing question is whether this procedure may also have clinical 
applications. In many ways, the present procedure represents a method of administering an 
intervention to a patient without direct contact with the body, albeit only in regard to inducing a 
placebo effect. While this is contingent on conditioning not being a necessary part of the procedure, as 
discussed above, this method of clinical intervention may be particularly applicable if feasible in 
conjunction with the virtual reality techniques discussed previously. Such a procedure may be able to 
instigate a placebo effect with no bodily interaction whatsoever, that is, without the need for 
synchronous visuo-tactile stimulation. This may be especially pertinent to conditions where interacting 
with the body can cause discomfort or pain, such as fibromyalgia or CPRS. Further, if successful, such a 
procedure may have application to diseases and disorders outside of pain which are responsive to the 
placebo effect. Previous research also indicates that even placebos are capable of producing unpleasant 
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side effects in patients.
3 46
 As the present paradigm entails no interaction between the treatment and 
the body, it may have the potential to circumnavigate such side effects. Future research should aim to 
examine whether this is the case by comparing the rate of side effects between a placebo treatment 
applied to the body and one applied to an artificial limb. 
Strangely, no difference was found in subjective ratings of tactile embodiment between 
conditions of visuo-tactile synchronicity, although a difference was noted when non-responders to the 
RHI were excluded. This finding is difficult to explain given the consistent replicability of this finding both 
within the literature in general, as well as the significant differences found within the other subjective 
measures. While this result may simply be explained as an anomaly within the data, it could also be a 
product of the questionnaire. While the changes to the questionnaire proved to be reliable during pilot 
testing, removal of the range of responses in regard to an absence of the experience may have reduced 
the overall variance and contributed to this outcome. Further, the study also failed to find any effect of 
visuo-tactile synchronicity on the behavioural measure of proprioceptive drift, a finding in contrast to 
previous studies.
8 50
 Akin to tactile embodiment, however, a difference in this measure was observed 
when non-responders were excluded. A potential explanation for this is that the method used in the 
present experiment required participants to estimate the location of their right arm using their left 
hand, this movement itself may have adversely affected the strength of the illusion and reduced the 
degree of proprioceptive drift towards the rubber hand. 
While the study observed an effect of a treatment applied in this manner without excluding 
participants who did not respond to the RHI, it remains that the sample size itself is still small. To these 
ends, the results presented here represent a proof of principle regarding this experimental paradigm 
which should be replicated in larger cohorts. Indeed, a larger sample size may yield further correlational 
findings between measures of the RHI and placebo analgesia. Further, although the procedure was 
designed to avoid clear demand characteristics, another research avenue should aim to replicate the 
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present findings and incorporate a surreptitious naloxone manipulation
5 
in order to demonstrate that 
the effect is mediated by neurobiological mechanisms. The present experiment also did not employ any 
measures of expectancy regarding the degree of pain relief. Such a measure was not used in order to 
avoid any association with placebo research in the participants. Nonetheless, recording expectations 
may have yielded interesting findings regarding the extent to which participants actually expected pain 
relief following the application of a placebo treatment to the artificial limb, as opposed to their own 
arm.  
In conclusion, the present study outlines an intriguing method of inducing a placebo effect, in 
which a sham topical anaesthetic is applied to a rubber arm unattached to the body, but is experienced 
as so through an illusion of bodily ownership. Such a finding demonstrates how experience of the body 
may alter treatment outcomes – a previously unexamined aspect of the treatment process with 
potential implications for treatment administration. 
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Figure 1. The experimental set-up, depicting the two sites on the real right arm and the artificial limb, as 
well as the partition obscuring view of the right arm (Figure adapted from Capelari et al.
 8
 Permission of 
Pion Ltd, London). 
Figure 2. The experimental procedure; three phases of thermal stimulation, split between two sites, 
were carried out under conditions of either synchronous or asynchronous stimulation. After baseline 
assessment a placebo and control treatment were applied to the rubber arm and intensity reduced at 
the site receiving the placebo. During post-treatment, this site was returned to baseline intensity (Figure 
adapted from Capelari et al.
8 
Permission of Pion Ltd, London). 
Figure 3. Mean, standard error, and effect size (Cohen’s d) for pain intensity ratings during the pre- and 
post-treatment phases at the placebo and control sites during both synchronous and asynchronous 
stimulation. Significant differences are marked with an asterisk (* p < .025). 
Figure 4. Mean, standard error, and effect size (Cohen’s d) for pain unpleasantness ratings during the 
pre- and post-treatment phases at the placebo and control sites during both synchronous and 
asynchronous stimulation. Significant differences are marked with an asterisk (* = p < .016). 
Table 1. Rubber hand illusion questionnaire.  
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Table 2. The procedure employed by in the experiment. Stimulation intensity was applied based on a 0-
100 pain rating scale. 
Table 3 .Means and standard deviation for subscales of the RHI questionnaire and proprioceptive drift 
(cm) across conditions of synchronicity, treatment, and phase. Significance of synchronous over 
asynchronous stimulation is marked with an asterisk (** = p < .01, * = p < .05). Note, the conditioning 
phase was not included in analyses.  
Table 4. Means and standard deviations for pain intensity across conditions of synchronicity, treatment, 
and phase. 
Table 5. Means and standard deviations for pain unpleasantness across conditions of synchronicity, 
treatment, and phase. 
Table 6. Correlation matrix between measures of pain intensity and unpleasantness and measures of 
the RHI at the placebo treatment site in the post-treatment phase, * indicates a significant level of .05, 
while ** indicates a significance level of .01. 
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Table 1. 
RHI Questionnaire 
1 It seemed as though the rubber hand were my hand. 
2 It seemed as if I were feeling the pain at the location where I saw the rubber hand stimulated. 
3 It seemed as though the pain I felt was caused by the painful stimulation of the rubber hand. 
4 It seemed as though the touch I felt was caused by the touching of the rubber hand. 
5 It seemed as if I were feeling the touch in the location where I saw the rubber hand touched. 
 
Table 2. 
 
Pre-Treatment Conditioning Post-Treatment 
Placebo 60 (2 blocks) 30 (2+1 blocks) 60 (2 blocks) 
Control 60 (2 blocks) 60 (2+1 blocks) 60 (2 blocks) 
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Table 3. 
 Subscales of the RHI 
 Ownership 
    Pre-Treatment Conditioning Post-Treatment 
Placebo Synchronous 2.30 (1.81) ** 2.45 (1.90) 2.40 (1.96) ** 
Control Synchronous 2.45 (1.79) ** 2.60 (1.82) 2.55 (1.79) ** 
Placebo Asynchronous 1.45 (1.64) 1.65 (1.76) 1.65 (1.90) 
Control Asynchronous 1.25 (1.48) 1.40 (1.54) 1.70 (1.78) 
 Tactile Embodiment 
 Pre-Treatment Conditioning Post-Treatment 
Placebo Synchronous 2.50 (1.96) 2.58 (1.95) 2.33 (1.86) 
Control Synchronous 2.38 (1.85) 2.68 (1.90) 2.33 (1.68) 
Placebo Asynchronous 1.73 (1.59) 1.90 (1.75) 1.85 (1.92) 
Control Asynchronous 1.50 (1.61) 1.65 (1.77) 2.00 (1.77) 
 Nociceptive Embodiment 
 Pre-Treatment Conditioning Post-Treatment 
Placebo Synchronous 1.68 (1.84) ** 1.73 (1.87) 2.05 (2.08) ** 
Control Synchronous 1.63 (1.75) ** 1.88 (2.00) 1.80 (1.92) ** 
Placebo Asynchronous 0.80 (1.15) 1.25 (1.54) 1.10 (1.64) 
Control Asynchronous 0.88 (1.26) 1.03 (1.33) 1.13 (1.57) 
  Proprioceptive Drift 
 
Pre-Treatment Conditioning Post-Treatment 
Placebo Synchronous 1.16 (3.38) 1.28 (3.30) 1.17 (2.68) 
Control Synchronous 1.37 (3.44) 0.03 (3.25) 1.93 (2.17) 
Placebo Asynchronous 0.89 (3.23) 0.71 (2.62) 0.22 (3.10) 
Control Asynchronous 1.17 (3.02) 0.64 (4.46) -0.03 (1.90) 
 
Table 4. 
  Intensity – Synchronous Stimulation Intensity – Asynchronous Stimulation 
 Placebo Control Placebo Control 
Pre-treatment 56.3 (9.9) 55.7 (12.8) 53.1 (13.7) 58.0 (11.5) 
Conditioning 29.6 (11.4) 57.0 (12.9) 27.9 (13.8) 59.6 (15.4) 
Post-treatment 50.0 (14.5) 60.8 (14.2) 54.3 (20.3) 58.2 (20.0) 
Pre-Post Difference -6.3 (14.5) 5.1 (10.8) 1.2 (13.9) 0.2 (15.1) 
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Table 5. 
  
Unpleasantness - Synchronous 
Stimulation 
Unpleasantness - Asynchronous 
Stimulation 
 
Placebo Control Placebo Control 
Pre-treatment 46.4 (13.4) 46.6 (13.9) 43.4 (17.9) 51.3 (17.1) 
Conditioning 21.0 (10.3) 48.7 (14.4) 21.1 (16.5) 53.2 (20.7) 
Post-treatment 43.5 (16.3) 53.8 (19.0) 46.9 (23.6) 52.0 (22.6) 
Pre-Post Difference -2.9 (15.2) 7.2 (10.7) 3.5 (13.4) 0.7 (13.5) 
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Table 6.  
 
  Intensity Intensity Pre – Post 
Intensity Placebo – 
Control Unpleasantness 
Unpleasantness Pre 
– Post 
Unpleasantness 
Placebo – Control 
Ownership Pre -.053 -.249 .111 -.052 -.171 .107 
Tactile Embodiment 
Pre -.005 -.280 .290 -.006 -.209 .284 
Pain Embodiment Pre -.411 -.433 .247 -.332 -.467* .199 
Ownership Post -.035 -.334 .312 .087 -.012 .295 
Tactile Embodiment 
Post -.121 -.384 .396 -.071 -.125 .347 
Pain Embodiment Post -.341 -.483* .287 -.205 -.335 .246 
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Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 
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Figure 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 
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Placebo Analgesia from a Rubber Hand – Highlights 
 
- The rubber hand illusion is an illusion of embodiment over an artificial limb. 
- A sham analgesic applied to the rubber hand can produce placebo analgesia. 
- Embodiment may influence expectations of treatment efficacy and the placebo effect. 
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